Abstract: Disclosed are a dark-field confocal microscopic measurement apparatus and method based on vortex dichroism. The apparatus includes an array vortex light generation module, an array vortex light illumination module and an array dark-field confocal detection module; an array vortex wave plate of the array vortex light generation module generates vortex light to illuminate a sample of the array vortex light illumination module; and the array dark-field confocal detection module extracts scattering signals, and identifies differences between scattering signals collected under the illumination of opposite-order vortex light.

Abstract: A capacitor structure, including a transistor structure, a first metal conductive structure and a second metal conductive structure, is provided. The transistor structure includes a first ladder-shaped frame of a polycrystalline silicon layer and multiple first metal strips of a first metal layer. The first ladder-shaped frame is electrically isolated from the multiple first metal strips, and encircles a part of the multiple first metal strips. The first ladder-shaped frame forms a gate of the transistor structure. The multiple first metal strips form a drain and a source of the transistor structure. The first metal conductive structure is substantially overlapped with the first ladder-shaped frame. The second metal conductive structure is electrically connected to the multiple first metal strips, in which the second metal conductive structure is disposed across and electrically isolated from the first ladder-shaped frame and the first metal conductive structure.

Abstract: Disclosed are compounds of Formula I, or a salt thereof: where A, B, D, X, R1, R2 and R8 are as defined herein, which compounds have properties for antagonizing PCSK9. Also described are pharmaceutical formulations comprising the compounds of Formula I or their salts, and methods of treating cardiovascular disease and conditions related to PCSK9 activity, e.g. atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions.

Abstract: An information handling system may include at least one processor and a memory. The information handling system may be configured to determine names for a plurality of other information handling systems that are on-premises at a particular datacenter having a local network associated therewith; poll a selected subset of the plurality of other information handling systems via the local network; based on results of the polling, determine whether the information handling system is on-premises at the particular datacenter; and in response to a determination that the information handling system is on-premises at the particular datacenter, enable access to at least one sensitive administration operation associated with the particular datacenter.

Abstract: Provided are a dark-field confocal microscopy measurement apparatus and method.

Abstract: This application relates to the technical field of confocal microscopy measurement and provides a dark-field confocal microscopy measurement apparatus and method based on time-varying fractional-order vortex demodulation. The apparatus includes a time-varying modulated illumination module, an optical scanning module, a signal collection and demodulation module, a function generator, and a sample platform. The function generator is separately connected with. The time-varying modulated illumination module is configured to emit fractional-order vortex light to the optical scanning module. The optical scanning module is configured to transmit the fractional-order vortex light to the to-be-measured sample on the sample platform and transmit a reflected light signal to the signal collection and demodulation module.

Abstract: Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Nav1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Nav1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.

Abstract: This application provides a vortex dichroism dark-field confocal microscopy measurement apparatus based on spiral transformation. An opposite-order vortex beam generation module is configured to generate a mixed vortex beam, a sample scanning module is configured to irradiate a scanning position of a to-be-measured sample by using the mixed vortex beam, to obtain a sample reflection beam. A spiral transformation module is configured to spatially separate the sample reflection beam to obtain spatially separated beams. A multi-order detection module is configured to detect the spatially separated beams to obtain a vortex dichroism signal at the scanning position. When the scanning position of the to-be-measured sample is defect-free, the vortex dichroism signal is zero. Conversely, when defects are present at the scanning position, the vortex dichroism signal is non-zero. The positive and negative the vortex dichroism signal respectively correspond to the left-handed and right-handed chirality of the defects.

Abstract: The present disclosure provides an intralocular-lens (IOL) or ophthalmic device including an optic and at least one haptic, at least a portion of which is formed from a photoresponsive shape memory polymer network, such as a polydomain azo liquid crystalline polymer network (PD-LCN). The present disclosure further provides systems and methods for adjusting the position of such an IOL or other ophthalmic device using polarized laser radiation.

Abstract: A Domain Name System (DNS) configuration processing method is performed by User Equipment (UE), and includes: receiving a second DNS configuration sent by a network device; and determining a DNS configuration used by the UE according to the second DNS configuration and a first DNS configuration.

Abstract: The present application discloses an information transmission method and apparatus, a communication device and a storage medium. The method comprises: a ranging server receives a collaborative ranging request message from a ranging request terminal, the collaborative ranging request message requesting collaborative ranging with respect to a target user equipment (UE); and determining whether to perform collaborative ranging at least according to the privacy configuration information of the target UE.

Abstract: Example methods, devices, and computer program products are provided. An example method includes receiving, by a third process, a first render tree generated by a first process. The first render tree is configured to draw an interface associated with the first process and a first display region. The method includes generating, by the third process, a first interface based on the first render tree. The first interface comprises the interface associated with the first process, on the first display region. The method includes receiving, by a fourth process, a second render tree generated by a second process. The second render tree is configured to draw an interface associated with the second process, on the first display region. The method includes generating, by the fourth process, a second interface based on the second render tree. The second interface comprises the interface associated with the second process, on a second display region.

Abstract: An access mode switching method includes: obtaining access mode switching information, and switching a network accessed by a user equipment (UE) between a stand-alone non-public network (SNPN) and a public land mobile network (PLMN).

Abstract: Disclosed are compounds of Formula A, or a pharmaceutically acceptable salt thereof: where A, X, R1, and R2 are as defined herein, which compounds have properties for antagonizing PCSK9. Also described are pharmaceutical formulations comprising the compounds of Formula I or their salts, and methods of treating cardiovascular disease and conditions related to PCSK9 activity, e.g. atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions.

Abstract: Propylene-ethylene copolymers are provided that exhibit superior tensile strength and mechanical properties due to their specific propylene and ethylene content, triad tacticity, viscosity, and crystallinity. Moreover, we have discovered that certain processing conditions, such as polymerization temperature and external donor to catalyst ratios, can facilitate the production of the high tensile strength propylene-ethylene copolymers described herein. Furthermore, the high tensile strength propylene-ethylene copolymers may be used to produce a variety of hot melt adhesives, such as those for hygiene applications, woodworking applications, lamination applications, and packaging applications, which exhibit unique and superior mechanical properties.

Abstract: Provided are an ozone catalytic elimination device and a plasma beauty instrument including the ozone catalytic elimination device. The ozone catalytic elimination device includes an air pumping device, a catalytic device, a heating device, and a cooling device. An air inlet end of the air pumping device is used for communicating with an ionization cavity of the plasma beauty instrument, an air outlet end of the air pumping device communicates with the catalytic device, and ozone generated by the ionization cavity can be pumped to the catalytic device by the air pumping device. The catalytic device is configured to catalyze the ozone into oxygen, the heating device can be configured to heat the ozone, the cooling device communicates with the interior of the catalytic device, and the cooling device can be configured to cool the oxygen.

Abstract: A biochemical substance analysis system is used to detect biological characteristics of a sample in a flow cell, and includes a detection system, a scheduling system, a biochemical reaction system, and a control system. The scheduling system is used to schedule the flow cell at different sites, including sites in the detection system and sites in the biochemical reaction system. The biochemical reaction system is used to allow the sample to react in the flow cell. The detection system is used to detect a signal from the reacted sample to obtain a signal representing the biological characteristics of the sample. The control system is used to control the detection system, the scheduling system, and the biochemical reaction system to cooperate. The present disclosure improves the automation degree and flux of the biochemical substance analysis.

Abstract: Provided in embodiments of the present disclosure are a wireless sensing method and apparatus, a communication device, and a storage medium. The method includes: based on a sensing service. sending a sensing service request to a sensing function. The sensing service request is at least used by the sensing function to configure a sensing parameter of the sensing service.

Abstract: A drying air duct, a clothing treatment device and a method for cleaning a drying air duct are provided. The drying air duct includes a condensing section air duct, a heating section air duct and a fan; the fan is provided at a connection position of the condensing section air duct and the heating section air duct, a cleaning device is provided in the condensing section air duct, the cleaning device is provided at an end of the condensing section air duct adjacent to the fan and is capable of cleaning a side of the condensing section air duct away from the fan. The drying air duct can effectively clean the pipe sudden expansion area of the condensing section air duct, preventing the accumulation of soft flocks in the condensing section air duct.

Abstract: A batch private information retrieval method and apparatus, including: agreeing on a hash function, calculating a serial number index in an original database, retaining a result of each serial number index for each hash function, and obtaining a first hash bucket; filling an index of a batch query into a second hash bucket of a same length as the first hash bucket by the client, and encoding a filling result by using a constant weight code encoding manner; encrypting an obtained encoding result as a batch query request by the client; comparing the batch query request with the first hash bucket by the server to obtain a corresponding intermediate result, calculating correspondingly the intermediate result and the original database to obtain a corresponding query result ciphertext; and decrypting the query result ciphertext by the client, and thus simultaneously obtaining a query result of the batch query request.